131 related articles for article (PubMed ID: 38507296)
61. Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy.
Saleh Faisal M; Jamil A; Ali N; Alshahrani AM; Almarshad F
Gene; 2024 Jan; 892():147886. PubMed ID: 37820941
[TBL] [Abstract][Full Text] [Related]
62. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.
Lin WW; Li XW; Jiao Z; Zhang J; Rao X; Zeng DY; Lin XH; Wang CL
Eur J Clin Pharmacol; 2019 Mar; 75(3):381-392. PubMed ID: 30456415
[TBL] [Abstract][Full Text] [Related]
63. Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on dose-adjusted plasma levels of carbamazepine in epileptic patients in South Indian population.
Ganesapandian M; Ramasamy K; Adithan S; Narayan SK
Indian J Pharmacol; 2019; 51(6):384-388. PubMed ID: 32029960
[TBL] [Abstract][Full Text] [Related]
64. Prevalence of ABCB1 3435C>T polymorphism in the Cuban population.
Rodeiro Guerra I; Herrea J; Cuétara E; Garrido G; Reyes E; Martínez I; Pérez CL; Fernández G; Hernández-Balmaseda I; Delgado R; Stingl JC; Berghe WV
Drug Metab Pers Ther; 2021 Dec; 37(2):141-148. PubMed ID: 34860473
[TBL] [Abstract][Full Text] [Related]
65. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM
Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507
[TBL] [Abstract][Full Text] [Related]
66. Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy.
Sharma P; Singh N; Sharma S
J Gene Med; 2023 Jan; 25(1):e3460. PubMed ID: 36314103
[TBL] [Abstract][Full Text] [Related]
67. The Impact of ABCB1 SNPs on Tacrolimus Pharmacokinetics in Liver or Kidney Transplant Recipients: A Meta-analysis.
Li Z; Wang X; Li D; Cheng S; Dong Y; Yang H; Li X
Curr Pharm Des; 2023; 29(29):2323-2335. PubMed ID: 37817654
[TBL] [Abstract][Full Text] [Related]
68. Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs.
Hung CC; Chen CC; Lin CJ; Liou HH
Pharmacogenet Genomics; 2008 May; 18(5):390-402. PubMed ID: 18408562
[TBL] [Abstract][Full Text] [Related]
69. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
[TBL] [Abstract][Full Text] [Related]
70. New-onset interictal headache in Persons with epilepsy (PWE): A case-control study.
Sahu J; Nair PP; Wadwekar V; Aghoram R
Epilepsy Behav; 2018 Nov; 88():172-175. PubMed ID: 30290325
[TBL] [Abstract][Full Text] [Related]
71. Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.
Jakobsen Falk I; Lund J; Gréen H; Gruber A; Alici E; Lauri B; Blimark C; Mellqvist UH; Swedin A; Forsberg K; Carlsson C; Hardling M; Ahlberg L; Lotfi K; Nahi H
Cancer Chemother Pharmacol; 2018 Jan; 81(1):183-193. PubMed ID: 29177954
[TBL] [Abstract][Full Text] [Related]
72. Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey.
Ozgon GO; Bebek N; Gul G; Cine N
Eur Neurol; 2008; 59(1-2):67-70. PubMed ID: 17917461
[TBL] [Abstract][Full Text] [Related]
73. Interictal autonomic changes in persons with epilepsy (PWE) on carbamazepine (CBZ) versus other anti-seizure drug monotherapy: A cross-sectional study.
Jain S; Nair PP; Aghoram R; Wadwekar V; Wagh S; Balachandran M; Indira Priya D; Meher R; Nandwani S; Sreekumaran Nair N
Epilepsy Behav; 2021 Dec; 125():108396. PubMed ID: 34788731
[TBL] [Abstract][Full Text] [Related]
74. Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy.
Shen C; Zhang B; Liu Z; Tang Y; Zhang Y; Wang S; Guo Y; Ding Y; Wang S; Ding M
Seizure; 2017 Oct; 51():102-106. PubMed ID: 28837897
[TBL] [Abstract][Full Text] [Related]
75. Association of polymorphisms in NR1I2 and ABCB1 genes with epilepsy treatment responses.
Hung CC; Jen Tai J; Kao PJ; Lin MS; Liou HH
Pharmacogenomics; 2007 Sep; 8(9):1151-8. PubMed ID: 17924830
[TBL] [Abstract][Full Text] [Related]
76. Assessment of the Link of
Parvin MN; Aziz MA; Rabbi SNI; Al-Mamun MMA; Hanif M; Islam MS; Islam MS
J Adv Res; 2021 Nov; 33():141-151. PubMed ID: 34603785
[TBL] [Abstract][Full Text] [Related]
77. Vigabatrin versus carbamazepine monotherapy for epilepsy.
Xiao Y; Gan L; Wang J; Luo M; Luo H
Cochrane Database Syst Rev; 2012 Jan; 1():CD008781. PubMed ID: 22258989
[TBL] [Abstract][Full Text] [Related]
78. ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.
Panczyk M; Balcerczak E; Piaskowski S; Jamroziak K; Pasz-Walczak G; Mirowski M
Int J Colorectal Dis; 2009 Aug; 24(8):895-905. PubMed ID: 19415305
[TBL] [Abstract][Full Text] [Related]
79. Presence of allele CYP3A4*16 does not have any bearing on carbamazepine-induced adverse drug reactions in North Indian people with epilepsy.
Garg VK; Goyal MK; Khullar M; Saikia B; Medhi B; Prakash A; Prabhat N; Tandyala N; Mahesh KV; Kharbanda PS; Prabhakar S; Modi M; Lal V; Shree R; Sachdeva J
Indian J Pharmacol; 2020; 52(5):378-382. PubMed ID: 33283769
[TBL] [Abstract][Full Text] [Related]
80. Vigabatrin versus carbamazepine monotherapy for epilepsy.
Xiao Y; Gan L; Wang J; Luo M; Luo H
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008781. PubMed ID: 26580100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
